Precipio Diagnostics: Funding, Investors & Team (Sep 2026)
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis.
Precipio Diagnostics has raised $500k across 1 funding round on record, the most recent an undisclosed round of $500k announced in May 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Precipio Diagnostics Company Profile and Key Stats
Latest funding round on record: May 2024.
Precipio Diagnostics Funding Rounds
Precipio Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Precipio Diagnostics Funding Compared to Other Biotechnology Startups
Precipio Diagnostics' latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Precipio Diagnostics in Biotechnology and New Haven
Companies Similar to Precipio Diagnostics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Precipio Diagnostics Funding FAQs
What does Precipio Diagnostics do?
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis.
How much funding has Precipio Diagnostics raised?
Precipio Diagnostics has raised $500k across 1 round on record. The most recent is an undisclosed round of $500k announced in May 2024.
When did Precipio Diagnostics last raise funding?
Precipio Diagnostics' most recent funding round on record is an undisclosed round of $500k, announced in May 2024.
Who founded Precipio Diagnostics?
FundedIQ lists Ilan Danieli (Founder) at Precipio Diagnostics.
Where is Precipio Diagnostics headquartered?
Precipio Diagnostics is based in New Haven, Connecticut, United States.
How many employees does Precipio Diagnostics have?
Precipio Diagnostics is in the 51-100 employee band.
How does Precipio Diagnostics' funding compare to other Biotechnology startups?
Precipio Diagnostics' latest round of $500k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Precipio Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Precipio Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.